510(k) device
Glean Urodynamics System Male Delivery System (GUS-1000-M)
Bright Uro, Inc. · Cystometer, Electrical Recording (EXQ, Class II) · First FDA decision Mar 24, 2025, newest Apr 16, 2026Overactive bladder and urinary incontinence
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
5
Naming "Glean Urodynamics"
MAUDE reports
0
Brand "Glean Urodynamics", since 2015
PubMed studies
3
Mentioning "Glean Urodynamics"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Glean Urodynamics System Male Delivery System (GUS-1000-M)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
K253537 · Decided Apr 16, 2026 · 154 days after receipt
Device type: Cystometer, Electrical Recording (EXQ) · GI, Urology & Nephrology
K243052 · Decided Mar 24, 2025 · 178 days after receipt
Device type: Cystometer, Electrical Recording (EXQ) · GI, Urology & Nephrology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Glean Urodynamics", any status and sponsor, newest update first.
- Establishing Normative Urodynamics Parameters for the Glean Urodynamics System in Healthy AdultsRecruiting
Bright UroNot on our public-company list
NCT07485205 · 72 participants (planned) · Start Mar 31, 2026 · Primary completion Mar 2027
Device: Glean Urodynamics System · For: Lower Urinary Tract Symptoms (LUTS)
Sites: Phoenix, Arizona; Tucson, Arizona; Tustin, California
Bright UroNot on our public-company list
NCT07425015 · 101 participants (planned) · Start Feb 17, 2026 · Primary completion Jun 2027
Device: Glean Urodynamics System · For: Urology; Urinary Bladder, Overactive; Benign Prostatic Hyperplasia and 4 more
Sites: New Orleans, Louisiana; Hanover, Maryland; Owings Mills, Maryland · 9 sites in all
Bright UroNot on our public-company list
NCT05694793 · 30 participants · Start Jun 3, 2025 · Primary completion Jul 27, 2026
Device: Glean Urodynamics System; Glean Urodynamics System · For: Urologic Diseases; Urodynamics
Sites: Murrieta, California; San Diego, California; Cleveland, Ohio
2 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Glean Urodynamics", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code EXQ
1 reports: 1 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Glean Urodynamics"[tiab]. The summary above synthesizes these.
- Comparative Pressure Measurement Performance of the Glean Urodynamics System-a Novel Wireless and Catheter-Free Urodynamics Device.
Hamson M, Maahs T, Poulsen A, et al. · J Endourol · 2026Comparative Study
- The Feasibility and Safety of the Glean Urodynamics System: The Modern Urodynamics System Efficacy Study.
Kim J, Xavier K, Cannon-Smith T, et al. · J Endourol · 2025Multicenter Study, Clinical Trial
- Letter: Comment on "The Feasibility and Safety of the Glean Urodynamics System: The Modern Urodynamics System Efficacy Study".
Memon W, Mehta R, Sah R · J Endourol · 2026Letter
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.